Skip to content
Online Prescribing
  • Home
  • Services
    • Consultancy
    • Subscribe
    • Guarantee
  • Shop
  • Blog
  • About Us
  • Contact Us
    • Survey

Psychedelic-Assisted Psychotherapy

  • Home
  • Blog
  • Psychedelics
  • Psychedelic-Assisted Psychotherapy
  • Page 2

Psilocybin availability in the UK

Posted by By Mike Bereza February 28, 2021Posted inDepression, Digital Health, Psychedelic-Assisted Psychotherapy11 Comments
When will psilocybin be legally available in the UK? It is no secret in the medical sector, that evidence for the efficacy of traditional antidepressants (SSRIs, SNRIs, NASSAs...) is underwhelming.…
Read More

Can pharmacists prescribe cannabis-based medicines?

Posted by By Mike Bereza January 27, 2021Posted inDigital Health, New Medicines, Psychedelic-Assisted PsychotherapyNo Comments
Who can prescribe cannabis in the UK? Currently, prescribing pharmacists in the UK cannot prescribe cannabis-based products for medicinal use (CBPMs). Prescribing of CBPMs for medicinal use in the UK…
Read More

Esketamine as an Antidepressant

Posted by By Mike Bereza May 22, 2019Posted inDigital Health, New Medicines, Psychedelic-Assisted Psychotherapy, PsychedelicsNo Comments
Major depressive disorder (MDD) is a significant cause of disability worldwide and the most common illness preceding suicide. On March 5, 2019, the nasal spray drug, esketamine, also known as Spravato (by Janssen…
Read More

Esketamine availability in Australia

Posted by By Mike Bereza April 28, 2019Posted inDepression, Digital Health, New Medicines, Psychedelic-Assisted Psychotherapy5 Comments
Spravato is the brand name of esketamine, a glutamate receptor drug used for rapid depression treatment manufactured by Johnson & Johnson in the US. Esketamine is contained within the standard pharmaceutical…
Read More

Esketamine availability in the UK

Posted by By Mike Bereza March 10, 2019Posted inDigital Health, New Medicines, Psychedelic-Assisted Psychotherapy, Psychedelics3 Comments
Spravato is the brand name of esketamine, a nasally adminitsered medicine used for the rapid treatment of moderate to severe depression. Spravato was initially released by Johnson & Johnson  in…
Read More

Posts pagination

Previous page 1 2

Recent Posts

  • How Ibogaine Differs from Other Psychedelic Therapies: A Clinical Comparison
  • Australian Online Prescribing Requirements
  • US Online Prescribing Requirements
  • UK Online Prescribing Requirements
  • List of Controlled Drugs on Ships

Recent Comments

  1. Mike Bereza on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
  2. Teresa on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
  3. Mike Bereza on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
  4. Janine on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
  5. Mike Bereza on Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
Copyright 2025 — Online Prescribing. All rights reserved.
Scroll to Top